We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Genome-wide Association Study Identifies New Bipolar Disorder Loci

By LabMedica International staff writers
Posted on 13 May 2019
Print article
Image: Brain imaging studies have revealed differences in the volume of various brain regions between patients with bipolar disorder and healthy control subjects (Photo courtesy of Wikimedia Commons).
Image: Brain imaging studies have revealed differences in the volume of various brain regions between patients with bipolar disorder and healthy control subjects (Photo courtesy of Wikimedia Commons).
Results obtained by a large genome-wide association study performed on individuals with bipolar disorder identified 20 new genetic associations involving genes encoding ion channels, neurotransmitter transporters, and synaptic components.

Bipolar disorder, previously known as manic depression, is a mental disorder affecting approximately 60 million people worldwide that causes periods of depression and periods of abnormally elevated mood. The risk of suicide among those with the illness is high at greater than 6% over 20 years, while self-harm occurs in 30-40%. The causes of the disorder are not clearly understood, but both environmental and genetic factors play a role. Many genes of small effect contribute to risk. Environmental risk factors include a history of childhood abuse and long-term stress.

The condition is classified as bipolar I disorder if there has been at least one manic episode, with or without depressive episodes, and as bipolar II disorder if there has been at least one hypomanic episode (but no manic episodes) and one major depressive episode. Bipolar I disorder is strongly genetically correlated with schizophrenia, driven by psychosis, whereas bipolar II disorder is more strongly correlated with major depressive disorder.

To identify genes associated with bipolar disorder, investigators at the Mount Sinai School of Medicine (New York, NY, USA) and at more than 200 collaborating institutions performed a genome-wide association study (GWAS) including 20,352 cases and 31,358 controls of European descent, with follow-up analysis of 822 gene loci in an additional 9,412 cases and 137,760 controls.

Analysis of the results revealed 30 loci that were significant genome-wide, including 20 newly identified loci. The significant loci contained genes encoding ion channels, neurotransmitter transporters, and synaptic components. Pathway analysis revealed nine significantly enriched gene sets, including those regulating of insulin secretion and endocannabinoid signaling. Eight of the genes linked to bipolar disorder harbored schizophrenia associations as well.

"The crux of this international collaborative study was, in essence, to connect the dots," said first author Dr. Eli Stahl, assistant professor of genetics and psychiatry at Mount Sinai School of Medicine. "By discovering new genes associated with bipolar disorder and demonstrating their overlap with genes found in other psychiatric disorders, we bring ourselves closer to finding the true genetic underpinnings of the disease and improving patient outcomes."

The bipolar disorder GWAS paper was published in the May 1, 2019, online edition of the journal of Nature Genetics.

Related Links:
Mount Sinai School of Medicine

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
One Step HbA1c Measuring System
GREENCARE A1c
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Molecular Diagnostics

view channel
Image: MOF materials efficiently enrich cfDNA and cfRNA in blood through simple operational process (Photo courtesy of Science China Press)

Blood Circulating Nucleic Acid Enrichment Technique Enables Non-Invasive Liver Cancer Diagnosis

The ability to diagnose diseases early can significantly enhance the effectiveness of clinical treatments and improve survival rates. One promising approach for non-invasive early diagnosis is the use... Read more

Hematology

view channel
Image: The low-cost portable device rapidly identifies chemotherapy patients at risk of sepsis (Photo courtesy of 52North Health)

POC Finger-Prick Blood Test Determines Risk of Neutropenic Sepsis in Patients Undergoing Chemotherapy

Neutropenia, a decrease in neutrophils (a type of white blood cell crucial for fighting infections), is a frequent side effect of certain cancer treatments. This condition elevates the risk of infections,... Read more

Pathology

view channel
Image: The OvaCis Rapid Test discriminates benign from malignant epithelial ovarian cysts (Photo courtesy of INEX)

Intra-Operative POC Device Distinguishes Between Benign and Malignant Ovarian Cysts within 15 Minutes

Ovarian cysts represent a significant health issue for women globally, with up to 10% experiencing this condition at some point in their lives. These cysts form when fluid collects within a thin membrane... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.